Radiochemistry & Molecular Imaging Probes

Share
Print
Back to Top

Overview

Jason S. Lewis
Director

At Memorial Sloan Kettering, researchers have translated numerous new radiopharmaceuticals into the clinic for both imaging and therapy purposes. The Radiochemistry and Molecular Imaging Probe (RMIP) Core Facility serves these investigators by supplying a variety of radiopharmaceuticals , including radiolabeled small molecules, peptides, antibodies, and nanoparticles that can be imaged by methods such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT). It also supplies nonradioactive molecular imaging probes for use with non-nuclear detection systems. Our services support both basic research investigations and patient imaging.

View More

Core group
Serge Lyashchenko in the cyclotron facility

Radiopharmacist Serge Lyashchenko preparing a reagent in the cyclotron facility.

Featured News

In the Clinic
Pictured: Serge Lyashchenko
How Our New Particle Accelerator Will Make Cancer Imaging and Treatment More Precise

The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail.
Novel Cancer-Targeting Investigational Nanoparticle Receives FDA IND Approval for First-In-Human Trial

Researchers at Memorial Sloan Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application (IND) from the US Food and Drug Administration (FDA) for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.

People

Jason S. Lewis

Director

Members

Serge K. Lyashchenko
Serge K. Lyashchenko

Assistant Attending

Shake Ahmmed
Shake Ahmmed

RMIP Core Radiopharmacist

Eva Burnazi
Eva Burnazi

Clinical Radiochemist

Steve Carlin
Steve Carlin

Clinical Radiochemist

Sam Frackowiak
Sam Frackowiak

Manager, RMIP Core Manufacturing

Sherron Hicks
Sherron Hicks

Cyclotron Engineer

Calvin Lom
Calvin Lom

Cyclotron Engineer

Hijin A. Park
Hijin A. Park

Lead, Nuclear Pharmacist

Giovanni Saint-Victor
Giovanni Saint-Victor

RMIP Core Systems Specialist

Aisha Shickler
Aisha Shickler

Senior Research Technician

Tricia Taylor
Tricia Taylor

RMIP Core Project Manager

Tuan Tran
Tuan Tran

Cyclotron Engineer

Angelo Valdivia
Angelo Valdivia

Sr. Radiopharmacy Technician

Scott Vietri
Scott Vietri

Lead, Nuclear Pharmacist

Jiong "Lilly" Wu
Jiong "Lilly" Wu

Research Technician, Sr.

Alumni
Ariel Brown
Ariel Brown

Radiopharmacy QA Specialist

Phillip DeNoble
Phillip DeNoble

RMIP Core Radiopharmacist

Yorann Roux
Yorann Roux

Clinical Radiochemist

Yiauchung "Howard" Sheh
Yiauchung "Howard" Sheh

Senior Cyclotron Engineer

Kevin Staton
Kevin Staton

Project Manager, Funds

Get in Touch

Related topics: